{"id":"NCT05540717","sponsor":"Allergy Therapeutics","briefTitle":"Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen","officialTitle":"A Randomised, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen Exposure","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-10-11","primaryCompletion":"2023-11-01","completion":"2023-11-01","firstPosted":"2022-09-15","resultsPosted":"2025-04-02","lastUpdate":"2025-04-02"},"enrollment":555,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis","Rhinoconjunctivitis"],"interventions":[{"type":"BIOLOGICAL","name":"PQ Grass","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"PQ Grass","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The PQGrass306 (G306) clinical trial is the pivotal Phase III efficacy clinical trial of PQ Grass.\n\nThe aim of the G306 pivotal clinical trial is to confirm the efficacy and safety of the optimal effective dose of PQ Grass 27600 SU. This will be determined through the measurements of the effect of PQ Grass on the symptoms of seasonal allergic rhinitis (SAR)/rhinoconjunctivitis and the use of relief medications to control these symptoms during the peak grass pollen season (GPS).","primaryOutcome":{"measure":"Combined Symptom and Medication Score (CSMS) Averaged Over the Peak Grass Pollen Season (GPS)","timeFrame":"dSS and dMS are recorded daily between Visit 8 (wk 16-29) and Visit 11 (wk 28-41). Then CSMS is adjusted to the Peak GPS, which depends on the GPS start and end dates for each region","effectByArm":[{"arm":"PQ Grass","deltaMin":1.08,"sd":null},{"arm":"Placebo","deltaMin":1.34,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.00048"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":102,"countries":["United States","Austria","Czechia","Germany","Hungary","Poland"]},"refs":{"pmids":["40626378"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":279},"commonTop":["Injection site erythema","Injection site swelling","Injection site pain","Injection site pruritus","Sneezing"]}}